Novo Nordisk’s Swedish history

Facts

Contact person:: Pål Brunnström
Financer:: Novo Nordisk
Responsible at MaU:: Pål Brunnström
Time frame:: 01 January 2026 - 31 December 2026
Faculty/department:: Faculty of Culture and Society

Department of Urban Studies
Research environment :: Institute for Urban Research

The Institute for Studies in Malmö's History (IMH)
Research subject:: History

Urban Studies

Business history

About the project

Novo Nordisk is a global healthcare company, founded in 1923 and headquartered in Denmark. Novo Nordisk Sweden is providing solutions for people living with diabetes, obesity, and other chronic diseases. Through the Novo Nordisk Foundation, Novo Nordisk actively support Swedish research, investing SEK 1.6 billion between 2019 and 2023 in leading institutions. Novo Nordisk Sweden and the Institute for Studies in Malmö’s History have recently initiated a collaboration to document Novo Nordisk’s history and lasting impact in Sweden.